INTRODUCTION

5
electrode puller (Narishege, East Meadow, NY). The seal of each electrode was evaluated under a light 108 microscope and the exposed portion of the carbon fiber was cut to ~75 µm. A silver print coated wire was 109 inserted into the lumen of the pipette to establish contact with the carbon fiber. Generally, the same 110 electrode was used each day and groups were interleaved with the order switching every day so that 111 potential error from slight variations in electrodes would be distributed equally between groups. At the 112 conclusion of each experiment, carbon fiber electrodes were calibrated in a flow cell using 1 µM lowered in 100 µm increments to optimize evoked dopamine release. At the initial and each subsequent 134 location, the SN was stimulated by administering 24 monophasic current pulses (4 ms/pulse) at a rate of 6 60 Hz (150 µA) while voltammetric recordings were made in the DLS. Once the peak DA signal was 136 optimized, pulse number (1-24 pulses) was altered across a range of frequencies (5-60 Hz) in descending 137 order. SN stimulation was delivered every 2 minutes, and peak oxidation current was measured.
138
Preliminary studies showed evoked DA release was independent of stimulation history. 
148
Electrode placement
149
At the end of each experiment, 2 µl Trypan blue dye (Sigma, MO) was injected at the carbon fiber 150 recording depth, and animals were then euthanized and perfused. Light microscopy was used to confirm 151 to confirm carbon fiber electrode placement within the DLS. Figure 1F shows placement of working 152 electrodes.
154
Statistical analysis
155
The data were tested for significance using ANOVA (R statistical software, version 2.12. 
215
Facilitation of DA release at low frequencies is abolished following deletion of β2* nAChR
216
In the β2*KO mice, dopamine release was drastically reduced across all pulses and frequencies 217 tested compared to WT mice (Fig 2; main effect of group, F (1,10) = 10.7, p < 0.01; frequency, F (3,10) = 9.7, p 9 < 0.01; pulse number, F (7,70) = 36.2, p < 0.001). At low frequencies, evoked DA release in β2*KO mice 219 does not rapidly increase with pulse number and asymptote at low pulse numbers as observed in WT 220 mice (Fig 2A/B 5 Hz, group, F (1,10) = 8.3, p < 0.05, group X pulse F (7,76) = 2.09, p = 0.054; 10 Hz, group 221 F (1,10) = 17.6, p < 0.01, group X pulse, not significant). For example, in WT 5 pulses at 5 Hz elicited ~75%
222
of maximal DA release at that frequency (Fig 2A, right panel) . In contrast, the same stimulation (5 pulses 223 @ 5Hz) only elicited ~9% of maximal release in β2*KO mice (Fig 2A, right panel) . To assess the relative 224 failure rate of DA release as a function of pulse number and frequency, we constructed survival plots for 225 each frequency (ie., 'survival' of release as pulse number decreases), where failures were defined as 226 currents that were too small to allow clear determination that DA was the oxidized species (see Methods).
227
In the β2*KO mice, release probability is greatly reduced across all pulse numbers at 5 Hz, with much 228 higher failure rates ( Fig 3A; Chi Square = 8.227; DF 1; p < 0.005). Together, these data suggest β2* 229 deletion degrades the low activity facilitation observed in wild-type.
230
In contrast, at higher frequencies (40 to 60 Hz), the shape of the β2*KO curves are similar to WT,
231
where DA release increases linearly with pulse number (Fig 2D-E) , with comparable failure rates (Fig 3B ; release across all pulses and frequencies tested (Fig 2; main effect of group, F (1,11) = 5.8, p < 0.05; 246 frequency, F (3,11) = 10.7, p < 0.01; pulse number, F (7,77) = 38.7, p < 0.001). Chronic nicotine, however, does 247 not completely abolish but severely diminishes nAChR facilitation of DA release at low frequencies.
248
Consistent with this partial retention of facilitation, we observe a trend towards increased failure rate of
249
DA release between cNIC and WT mice at 5 Hz (Fig 3A, 5 Hz, Chi-square = 3.358, DF:1; p = 0.067). At
250
higher frequencies (40 and 60 Hz), cNIC mice show the same monotonic linear relationship between 251 pulse and DA release seen in both WT control and β2*KO mice (Fig 2C-E ; no statistically significant 252 differences between groups), with comparable failure rates ( 
259
In the present in vivo study, we find both genetic deletion of β2* subunits (β2*KO) and chronic 260 nicotine (cNIC) dramatically reduces DA release across all frequencies and pulse numbers tested.
261
Although we see increased frequency-dependence of DA release in the absence of β2*nAChRs and
262
following chronic nicotine exposure, increasing frequency does not overcome reduced DA release; the 263 magnitude of reduction remains substantial even at high frequencies. These data suggest that chronically 264 inactivated or desensitized β2*nAChRs greatly attenuates the dynamic range of dopamine release in 265 response to dopamine cell activity.
266
In wild-type mice, we observe a facilitation of release in response to low stimulation protocols. At 
280
In β2*KO and cNIC mice, DA release is drastically reduced across all stimulation parameters.
281
Because we stimulated the midbrain, these data suggest a nAChR contribution to in vivo DA release,
282
independent of direct cholinergic interneuron stimulation. In addition, the low frequency facilitation 283 observed in WT is severely reduced, while scaling of DA release relative to pulse number is maintained at 284 higher frequencies. If release at higher frequencies is normalized to release at 1 pulse, the contrast 285 between high and low frequencies is higher in β2*KO and cNIC mice. This increased contrast, however,
286
has to be understood in the context of an overall decrease in dopamine release. In terms of absolute 287 magnitude of release, the difference between release at low and high frequencies in the β2*KO and cNIC 
297
In the current study, we administered chronic nicotine to mice via the drinking water. This method 298 is analogous to human smoking and allows for intermittent access to nicotine over a prolonged period 
316
Thus, reduced dopamine release observed in mice chronically treated with nicotine may arise as a 317 consequence of downregulation of α6β2* nAChRs on dopamine cell terminals.
318
In addition to being expressed on DA terminals, β2*nAChRs are expressed in the midbrain and 319 known to regulate dopamine cell activity. For example, activation of β2*nAChRs is thought to be 
